|
No.
|
Nom
de
médicament
|
Méthode
|
Matrice
|
VLIQ
*
|
|
1
|
Aceclofénac
|
HPLC-UV
|
Plasma
humain
|
0.204
µg/ml
|
|
2
|
Paracétamol
|
HPLC-UV
|
Plasma
humain
|
0.506
µg/ml
|
|
3
|
Acide
salicylique d'Acétyle et acide salicylique
|
HPLC-UV
|
Plasma
humain
|
0.050
µg/ml-Médicament et 0.401 µg/ml-Métabolite
|
|
4
|
Amlodipine
|
LC-MS/MS
2000
|
Plasma
humain
|
0.252
ng/ml
|
|
5
|
Amoxicillin
|
HPLC-UV
|
Plasma
humain
|
0.508
µg/ml
|
|
6
|
Amoxicillin
et acide Clavulanic
|
LC-MS/MS
3000
|
Plasma
humain
|
0.199
µg/ml - Amoxicillin et 0.020 µg/ml - acide
Clavulanic
|
|
7
|
Anastrozole
|
LC-MS/MS
3000
|
Plasma
humain
|
0.254
ng/ml
|
|
8
|
Aténolol
|
HPLC-FLU
|
Plasma
humain
|
10.057
ng/ml
|
|
9
|
Azithromycin
|
LC-MS/MS
2000
|
Plasma
humain
|
30.593
ng/ml
|
|
10
|
Bicalutamide
|
HPLC-UV
|
Plasma
humain
|
99.880
ng/ml
|
|
11
|
Bicalutamide
|
LC-MS/MS
2000
|
Plasma
humain
|
10.458
ng/ml
|
|
12
|
Carvédilol
|
HPLC-FLU
|
Plasma
humain
|
1.002
ng/ml
|
|
13
|
Céfaclor
|
HPLC-UV
|
Plasma
humain
|
0.208
µg/ml
|
|
14
|
Céfadroxil
|
HPLC-UV
|
Plasma
humain
|
0.502
µg/ml
|
|
15
|
Céfdinir
|
HPLC-UV
|
Plasma
humain
|
0.036
µg/ml
|
|
16
|
Céfixime
|
HPLC-UV
|
Plasma
humain
|
0.052
µg/ml
|
|
17
|
Céfprozil
|
HPLC-UV
|
Plasma
humain
|
0.201
µg/ml
|
|
18
|
Céftazidime
|
HPLC-UV
|
Plasma
humain
|
0.293
µg/ml
|
|
19
|
Céfuroxime
|
HPLC-UV
|
Plasma
humain
|
0.100
µg/ml
|
|
20
|
Céphalexin
|
HPLC-UV
|
Plasma
humain
|
0.297
µg/ml
|
|
21
|
Cétirizine
|
HPLC-UV
|
Plasma
humain
|
15.103
ng/ml
|
|
22
|
Cétirizine
|
LC-MS/MS
3000
|
Plasma
humain
|
4.989
ng/ml
|
|
23
|
Chlorthalidone
|
HPLC-UV
|
Plasma
humain
|
10.165
ng/ml
|
|
24
|
Ciprofloxacin
|
HPLC-FLU
|
Plasma
humain
|
51.480
ng/ml
|
|
25
|
Citalopram
|
HPLC-FLU
|
Plasma
humain
|
1.999
ng/ml
|
|
26
|
Acide
Clavulanic
|
HPLC-UV
|
Plasma
humain
|
0.050
µg/ml
|
|
27
|
Clopidogrel
|
LC-MS/MS
4000
|
Plasma
humain
|
10.200
pg/ml
|
|
28
|
Clopidogrel
carboxilic acide
|
HPLC-UV
|
Plasma
humain
|
99.975
ng/ml
|
|
29
|
Diclofénac
|
HPLC-UV
|
Plasma
humain
|
26.148
ng/ml
|
|
30
|
Diclofénac
|
LC-MS/MS
2000
|
Plasma
humain
|
5.137
ng/ml
|
|
31
|
Eprosartan
|
LC-MS/MS
2000
|
Plasma
humain
|
10.058
ng/ml
|
|
32
|
Flucloxacilin
|
HPLC-UV
|
Sérum
humain
|
0.299
µg/ml
|
|
33
|
Fluconazole
|
HPLC-UV
|
Plasma
humain
|
0.102
µg/ml
|
|
34
|
Fluvastatin
|
LC-MS/MS
4000
|
Plasma
humain
|
0.985
ng/ml
|
|
35
|
Gabapentin
|
LC-MS/MS
2000
|
Plasma
humain
|
151.969
ng/ml
|
|
36
|
Gliclazide
|
HPLC-UV
|
Plasma
humain
|
0.102
µg/ml
|
|
37
|
Glimépiride
|
LC-MS/MS
3000
|
Plasma
humain
|
0.500
ng/ml
|
|
38
|
Hydrochlorothiadize
|
LC-MS/MS
3000
|
Plasma
humain
|
1.008
ng/ml
|
|
39
|
Ibuprofène
|
HPLC-UV
|
Plasma
humain
|
0.720
µg/ml
|
|
40
|
Isotrétinoin
|
HPLC-UV
|
Plasma
humain
|
5.240
ng/ml
|
|
41
|
Itraconazole
& Hydroxy-Itraconazole
|
HPLC-FLU
|
Plasma
humain
|
5.047
ng/ml - Médicament et 5.054 ng/ml Métabolite
|
|
42
|
Kétoconazole
|
HPLC-FLU
|
Plasma
humain
|
0.050
µg/ml
|
|
43
|
Lamivudine,
Stavudine et Névirapine
|
LC-MS/MS
2000
|
Plasma
humain
|
0.052
µg/m - Lamivudine, 0.054 µg/ml - Stavudine et 0.048
µg/ml - Nevirapine
|
|
44
|
